相关实验视频
Updated: Jan 18, 2026

08:05
Murine Model of Allergen Induced Asthma
Published on: May 14, 2012
41.2K
2型高和低喘内型的机制和治疗方法
Timothy C Chin-See-Chong1, Jasper H Kappen1,2,3, Elizabeth Palmer2,3
1Department of Pulmonary Medicine, Franciscus Gasthuis & Vlietland, Rotterdam, the Netherlands.
概括
喘治疗正在推进,针对特定免疫路径的疗法正在推进. 过敏原特异性免疫疗法 (AIT) 和Tezepelumab等生物药物对各种喘类型,包括重症病例的新候选人,显示出前景.
科学领域:
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 喘是一种复杂的疾病,具有明显的2型高和2型低内型.
- 2型高喘包括过敏和eosinophilic非过敏的表型.
- 目前的治疗方法针对这些特定的免疫机制.
研究的目的:
- 审查目前和新的喘治疗策略.
- 突出对过敏原特异性免疫疗法 (AIT) 和生物制剂的疗效.
- 讨论中度至重度喘的新兴治疗方法.
主要方法:
- 对有关喘内型和治疗的现有文献的审查.
- 对已批准和新型喘治疗方法的临床试验数据的分析.
- 专注于免疫调节方法,包括AIT和生物制剂.
主要成果:
- 过敏特异性免疫疗法 (AIT) 对过敏性喘有效.
- 已批准的生物药物,包括介素抗剂和抗免疫球蛋白E,可以治疗喘.
- 德泽佩卢马布在治疗2型高喘和低喘方面表现有前途.
- 新型药物Itepekimab和depemokimab显示了积极的第二阶段结果.
结论:
- 针对2型免疫路径提供了有效的喘管理.
- 生物药物和AIT代表了喘治疗的重大进展.
- 新兴的治疗方法对难以治疗的喘患者有潜力.
相关概念视频
Asthma-II: Pathophysiology and Classification
4.1K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.1K
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Asthma-IV: Diagnostic and Management
3.1K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Antiasthma Drugs: Leukotriene Modifiers
1.8K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.8K
Asthma-I: Introduction
3.4K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.4K

